Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,692
datasets available to search
ShareScore release 0.9.0
Dataset results
2,692 results for “medicinal”
Highly cited tropical medicine articles in the early COVID 19 pandemic. Original Excel data on citation and subjects
<p><strong>ORIGINAL DATA SET FOR STUDY OF PUBLICATION AND CITATION TRENDS, TROPICAL MEDICINE, EARLY COVID 19 PANDEMIC. Background: </strong>An adequate response to health needs includes the identification of research patterns about the large number of people living in the tropics and subjected to tropical diseases. Studies have shown that research does not always match the real needs of those populations, and that citation reflects mostly the amount of money behind particular publications. Here we test the hypothesis that research from richer institutions is published in better-indexed journals, and thus has greater citation rates.</p> <p><strong>Methods:</strong> The data in this study was extracted from the Science Citation Index Expanded database; the 2020 journal Impact Factor (<em>IF</em><sub>2020</sub>) was updated to 30 June 2021. We considered places, subjects, institutions and journals.</p> <p><strong>Results:</strong> We identified 1 041 highly cited articles with 100 citations or more in the category of tropical medicine. About a decade is needed for an article to reach peak citation. Only two Covid-19 related were highly cited in the last three years. Most cited articles were published by the journals <em>Memorias Do Instituto Oswaldo Cruz</em> (Brazil), <em>Acta Tropica</em> (Switzerland), and <em>PLoS Neglected Tropical Diseases</em> (USA). The USA dominated five of the six publication indicators. International collaboration articles had more citations than single-country articles. The UK, South Africa, and Switzerland had high citation rates, as did the London School of Hygiene and Tropical Medicine in the UK, the Centers for Disease Control and Prevention in the USA, and the WHO in Switzerland.</p> <p><strong>Conclusions:</strong> About ten years of accumulated citations are needed to get 100 citations or more as highly cited articles in the Web of Science category of tropical medicine. Six publication and citation indicators, including authors’ publication potential and characteristics evaluated by <em>Y</em>-index, indicate that the currently available indexing system places tropical researchers at a disadvantage against their colleagues in temperate countries, and suggest that, to progress towards better control of tropical diseases, international collaboration should increase, and other tropical countries should follow the example of Brazil, which provides significant financing to its scientific community.Julián Monge-Nájera<sup>1</sup>, and Yuh-Shan Ho<sup>2</sup>*</p> <p><sup>1</sup>Laboratorio de Ecología Urbana, Vicerrectoría de Investigación, Universidad Estatal a Distancia, 2050 San José, Costa Rica; <a href="mailto:julianmonge@gmail.com"><em>julianmonge@gmail.com</em></a> (https://orcid.org/0000-0001-7764-2966)</p> <p>*Corresponding author: Trend Research Centre, Asia University, No. 500 Lioufeng Road, Wufeng, Taichung 41354, Taiwan; <a href="mailto:ysho@asia.edu.tw">ysho@asia.edu.tw</a> (<em>https://orcid.org/0000-0002-2557-8736</em>)</p>
Spanish wild plants traditionally used as medicine
<p>List of Spanish wild plant species with the ethnobotanical references in which they have been reported as medicinal and their cultural importance index (CI). Accompanied as well by data about origin (wild or cultivated), abundance, occupancy area, endemicity, conservation status, protection status. We also provide the complete list of references and legislation used.</p> <p>The excel file has five tabs: 1. Ethnobotanical references, 2. Medicinal species, 3. Legislation, 4. Protection, 5. Protection categories.</p>
Provenance, Added Clinical Benefit and Therapeutic Area of 632 medicines that entered the French market between 2008 and 2018
<p>This file contains a data set of 632 medicines that entered the French market between 2008 to 2018. 529 medicines are single drugs and 103 are combination medicines. For each drug we present data on provenance (inventor of the drug) and sources referencing our searches for origins of each medicine. We also present added clinical benefit data for all 632 medicines based on HAS and Prescrire matched grading scale as well as therapeutic area of each medicinal product in which the clinical benefit grading was sourced (highest clinical benefit grading attained by the product in the indication based on Prescrire grading). The file also contains data on the medicines approved by the FDA in the United States</p>
Dataset: Preliminary analysis of open data pertaining to the services available through the Health Insurance Institute of Slovenia and provided by family medicine
<p>BACKGROUND: The Health Insurance Institute of Slovenia (ZZZS) began publishing service-related data in May 2023, following a directive from the Ministry of Health (MoH). The ZZZS website provides easily accessible information about the services provided by individual doctors, including their names. The user is provided relevant information about the doctor's employer, including whether it is a public or private institution. The data provided is useful for studying the public system's operations and identifying any errors or anomalies. </p> <p>METHODS: The data for services provided in May 2023 was downloaded and analysed. The published data were cross-referenced using the provider's RIZDDZ number with the daily updated data on ambulatory workload from June 9, 2023, published by ZZZS. The data mentioned earlier were found to be inaccurate and were improved using alerts from the zdravniki.sledilnik.org portal. Therefore, they currently provide an accurate representation of the current situation. The total number of services provided by each provider in a given month was determined by adding up the individual services and then assigning them to the corresponding provider. </p> <p>RESULTS: A pivot table was created to identify 307 unique operators, with 15 operators not appearing in both lists. There are 66 public providers, which make up about 72% of the contractual programme in the public system. There are 241 private providers, accounting for about 28% of the contractual programme. In May 2023, public providers accounted for 69% (n=646,236) of services in the family medicine system, while private providers contributed 31% (n=291,660). The total number of services provided by public and private providers was 937,896. Three linear correlations were analysed. The initial analysis of the entire sample yielded a high R-squared value of .998 (adjusted R-squared value of .996) and a significant level below 0.001. The second analysis of the data from private providers showed a high R Squared value of .904 (Adjusted R Squared = .886), indicating a strong correlation between the variables. Furthermore, the significance level was < 0.001, providing additional support for the statistical significance of the results. The third analysis used data from public providers and showed a strong level of explanatory power, with a R Squared value of 1.000 (Adjusted R Squared = 1.000). Furthermore, the statistical significance of the findings was established with a p-value < 0.001. </p> <p>CONCLUSION: Our analysis shows a strong linear correlation between contract size of the program signed and number services rendered by family medicine providers. A stronger linear correlation is observed among providers in the public system compared to those in the private system. Our study found that private providers generally offer more services than public providers. However, it is important to acknowledge that the evaluation framework for assessing services may have inherent flaws when examining the data. Prescribing a prescription and resuscitating a patient are both assigned a rating of one service. It is crucial to closely monitor trends and identify comparable databases for pairing at the secondary and tertiary levels.</p>
EBSCO articles dataset (domain knowledge: rehabilitation medicine) + JSON of every article
<p><strong>EBSCO articles dataset (domain knowledge: rehabilitation medicine) + JSON of every article.</strong></p> <p><em>EBSCO articles dataset (parsed into JSON).zip</em> - an archive with structuring of each article in JSON format.</p> <p>This study would not have been possible without the financial support of the National Research Foundation of Ukraine (FundRef ID: 10.13039/100018227).</p> <p>Our work was funded by Grant contracts:</p> <p>– “Transdisciplinary intelligent information and analytical system for the re-habilitation processes support in a pandemic (TISP)”, application ID: 2020.01/0245 (2020–2021, project was success-fully completed);</p> <p>– “Development of the cloud-based platform for patient-centered telerehabilitation of oncology patients with mathematical-related modeling”, application ID: 2021.01/0136 (2022–2023, project is still in progress).</p>
Evidence-based medicine (EbM): Three-pillar model II
<p>The three-pillar model of evidence-based medicine (EbM) is based on integrating</p> <p>individual clinical expertise [professional knowledge, professional experience] with the best available external evidence from systematic research [studies/evidence/knowledge] and the wishes and needs of the patient [citizen/society/region].</p> <p>The ideas were introduced by David Lawrence Sackett (https://de.wikipedia.org/wiki/David_Sackett, https://ebmlive.org/). EbM has served and continues to serve the better treatment and care of patients based on scientifically verifiable, evident decisions.</p>
Evidence-based medicine (EbM): Three-pillar model I
<p>The three-pillar model of evidence-based medicine (EBM) is based on integrating</p> <p>individual clinical expertise [professional knowledge, professional experience] with the best available external evidence from systematic research [studies/evidence/knowledge] and the wishes and needs of the patient [citizen/society/region].</p> <p>The ideas were introduced by David Lawrence Sackett (https://de.wikipedia.org/wiki/David_Sackett, https://ebmlive.org/). EbM has served and continues to serve the better treatment and care of patients based on scientifically verifiable, evident decisions.</p>
Emergency Medicine Palliative Care Access
ClinicalTrials.gov study NCT03325985. IPD Sharing: YES. Countries: 1. Publications: 14.
Perinatal Precision Medicine
ClinicalTrials.gov study NCT03211039. IPD Sharing: YES. Countries: 1. Publications: 11.
Traditional medicinal use is linked with apparency, not specialized metabolite profiles in the order Caryophyllales
Open the record for dataset details and reuse information.
Preventative medicine? Examining prophylactic effects of a sunflower pollen diet in Bombus impatiens
Open the record for dataset details and reuse information.
Home and hub: pet trade and traditional medicine impact reptile populations in source locations and destinations
Open the record for dataset details and reuse information.
Extended data for Manuscript: Precision medicine implementation and research-practice partnerships: implications of measurement scale differential item functioning (DIF)
<p>This is the extended data for the manuscript submitted to F1000 Research titled:</p> <p>Precision medicine implementation and research-practice partnerships: implications of measurement scale differential item functioning (DIF).</p> <p>File 1 is the redacted survey responses from a card sort exercise carried out to find out how the study participants sorted and ranked various measures of factors thought to influence precision medicine implementation at health systems level.</p> <p>File 2 consists of the study package as described in the article</p>
Large scale virtual screening for finding inhibitor against the main protease from herbal medicine for SARS-Cov2 therapy
<p>The pandemic COVID-19 caused by SARS-CoV-2 has raised global health concerns. However, there is still no targeted medicine available for treatment of this disease. It is reported that 3CLpro plays an important role for the life cycle of virus and this protein has also been proved as an effective drug target in the case of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Medicinal plantsare important resource for drug discovery. Therefore, we executed large scale virtual screening on the herbal medicine library and hoped to find a potential drug againstthe main protease. As a result, we obtained three available compounds derived from Chinese herbal medicines through the docking and binding free energy calculation.Then 100 ns molecular dynamic (MD) were employed to uncover the potential mechanisms which is helpful for further drug optimization.</p>
Data from: Elevated atmospheric concentrations of carbon dioxide reduce monarch tolerance and increase parasite virulence by altering the medicinal properties of milkweeds
Hosts combat their parasites using mechanisms of resistance and tolerance, which together determine parasite virulence. Environmental factors, including diet, mediate the impact of parasites on hosts, with diet providing nutritional and medicinal properties. Here, we present the first evidence that ongoing environmental change decreases host tolerance and increases parasite virulence through a loss of dietary medicinal quality. Monarch butterflies use dietary toxins (cardenolides) to reduce the deleterious impacts of a protozoan parasite. We fed monarch larvae foliage from four milkweed species grown under either elevated or ambient CO2, and measured changes in resistance, tolerance, and virulence. The most high-cardenolide milkweed species lost its medicinal properties under elevated CO2; monarch tolerance to infection decreased, and parasite virulence increased. Declines in medicinal quality were associated with declines in foliar concentrations of lipophilic cardenolides. Our results emphasize that global environmental change may influence parasite-host interactions through changes in the medicinal properties of plants.
The ‘SAR Matrix’ method and its extensions for applications in medicinal chemistry and chemogenomics
<p>SD files of data sets reported in the manuscript that are used to generate the SARMs and CSMs are uploaded. The given data sets are represented by the corresponding figure numbers (as reported in the publication). The file format is provided in the file 'description.txt'.</p>
Molecular investigation of bacterial communities on two frequently used surfaces in the São Paulo institute of tropical medicine
<p>In this study, we aimed to investigate the overall bacterial population on two frequently used surfaces in the São Paulo institute of tropical medicine (ITM) using a culture-independent Illumina massively parallel sequencing approach of the 16S rRNA genes. The massive parallel sequencing data presented here were derived from the surface samples collected from restroom surfaces and the fingerprint door clock system (FDLS) in our ITM in São Paulo.</p>
Sex and Gender Medicine in Physician Clinical Training: Results of a Large, Single Center Survey
<p>This data set contains response data from the Gender Medical Curriculum survey referenced in the journal article, "Sex and Gender Medicine in Physician Clinical Training: Results of a Large, Single Center Survey".</p>
Research table for visualization of research performance of the German National Library of Science and Technology, German National Library of Medicine and German National Library of Economics via different communication channels
<p>A collection of data for (a practice) work during my studies for Bachelor. Since there wasn't much time given the data collection isn't as complete as it could be. Also, all text is in German.</p> <p>Definition of variables for data collection can be found in my finished work "How is reserach performance of the German National Library of Science and Technology, German National Library of Medicine and German National Library of Economics made visible via different communication channels; analysis of information of publication on official social media channels and news on offical webside" (in question to be published on Zenodo).</p> <p>Collected data from following official communication channels: Facebook, Twitter, Blogs, Google +, Youtube, Flickr, LinkedIn, Research-Gate, Slideshare, repository and news on websites. For some channels not all data could be collected. Research period from 01.08.2016 to 01.02.2017 (half a year).</p>
Data providers package for reporting monitoring results for veterinary medicinal product residues (2017 test phase)
<p>This data providers package provides the data collection configuration and supporting materials for reporting veterinary medicinal product residues (VMPR) results according to Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. These are to be used for the 2017 data reporting test phase.</p> <p>The package includes;</p> <p>Advice on the values to be reported for the mandatory fields specified for this data collection</p> <p>The Standard Sample Description Version 2 XML schema definition for VMPR reporting</p> <p>The STX transformation file which automatically assigns sampEventId and sampAnId when this information is not provided</p> <p>The general and VMPR specific business rules applied for the automatic validation of the submitted datasets</p> <p>The VMPR specific terminologies to be used for reporting analytical methods and the residues included in the scope of the analytical methods</p> <p>An excel tool which can support users in creating the required XML file for submission where automated data collation tools are not available and a manual for the tool</p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.